The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

30 articles for CH Wong


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors.EBI
National Taiwan University
Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.EBI
TBA
Tamiphosphor monoesters as effective anti-influenza agents.EBI
National Taiwan University
Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity.EBI
National Defense Medical Center, Taiwan
Development of oseltamivir phosphonate congeners as anti-influenza agents.EBI
The Genomics Research Center
Evaluation of sulfatase-directed quinone methide traps for proteomics.EBI
Bielefeld University
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.EBI
National Taiwan University
Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.EBI
National Taiwan University
High-throughput identification of fucosyltransferase inhibitors using carbohydrate microarrays.EBI
The Scripps Research Institute
Synthesis of sialyl Lewis X mimetics using the Ugi four-component reaction.EBI
Scripps Research Institute
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.EBI
The Scripps Research Institute
 
Design and synthesis of an α-mannosyl terpenoid as selective inhibitor of P-selectinEBI
TBA
 
Synthesis of C2-symmetrical polyhydroxyazepanes as inhibitors of glycosidasesEBI
TBA
 
Enzymatic synthesis of sialyl Lex and derivatives based on a recombinant fucosyltransferaseEBI
TBA
Isolation of Anti-SARS-CoV-2 Natural Products Extracted from EBI
National Taiwan University
Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3' residue.EBI
The Scripps Research Institute
Acceptor substrate-based selective inhibition of galactosyltransferases.EBI
Scripps Research Institute
Chemoenzymatic synthesis of iminocyclitol derivatives: a useful library strategy for the development of selective fucosyltransfer enzymes inhibitors.EBI
Scripps Research Institute
Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.EBI
Scripps Research Institute
Enhanced anti-influenza agents conjugated with anti-inflammatory activity.EBI
National Taiwan University
Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.EBI
National Taiwan University
A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant.EBI
The Scripps Research Institute
Tyrosine kinase inhibitor and uses thereofBDB
Xuanzhu Pharma
TrkA kinase inhibitors, compositions and methods thereofBDB
Merck Sharp & Dohme
Immune system modulatorsBDB
Janus Biotherapeutics
Pyridone FabI inhibitors and uses thereofBDB
The State University of New York
High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.BDB
Research Institute, Hospital For Sick Children
Enantiospecificity of glutamate carboxypeptidase II inhibition.BDB
Guilford Pharmaceuticals
Isoquinoline-pyridine-based protein kinase B/Akt antagonists: SAR and in vivo antitumor activity.BDB
Abbott Laboratories
Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.BDB
University of Auckland